Skip to main content

RPH3A KO cell line available to order. Free of charge wild type control provided.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human RPH3A knockout SK-N-FI cell line (AB288709), expandable thumbnail

Key facts

Cell type
SK-N-FI
Species or organism
Human
Tissue
Bone marrow
Form
Liquid
Knockout validation
Sanger Sequencing

Recommended products

RPH3A KO cell line available to order. Free of charge wild type control provided.

Key facts

Cell type
SK-N-FI
Form
Liquid
Disease
Neuroblastoma
Concentration
Loading...

Properties

Gene name
RPH3A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Cell culture

Biosafety level
EU: 1 US: 1
Viability
~ 80%
Adherent/suspension
Adherent
Gender
Male

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines

All seeding densities should be based on cell counts gained by established methods.

Culture medium
DMEM + 0.1 mM NEAA + 10 % FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Although we aim to provide customers with a homozygous clone, feasibility will be dependent on the biology of the protein. Should only heterozygous edits be achieved, you will be notified of the outcome and be asked to confirm whether the cell line is acceptable. All clones will be accompanied with DNA sequencing data, and the mutation description.

Recommended control: Human wild-type SK-N-FI cell line (ab288716). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

Cryopreservation cell medium: Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Culture medium:  DMEM + 0.1 mM NEAA + 10 % FBS  

Initial handling guidelines:

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.

2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.

3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.

4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.

5. Once confluent passage into an appropriate flask at a density of 2x10E4 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.  

Subculture guidelines:

• All seeding densities should be based on cell counts gained by established methods.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

Rabphilin 3A also known as RPH3A plays a role in exocytosis and synaptic transmission. This protein has a molecular weight of approximately 85 kDa. It contains domains that help in the interaction with small GTPases and phospholipids in the membrane. Rabphilin 3A is expressed in brain tissues particularly in neurons. It associates with synaptic vesicle membranes which is essential for neurotransmitter release at synapses.

Biological function summary

Rabphilin 3A modulates synaptic vesicle docking and fusion in the neuron. It acts as an effector of the small GTPase Rab3 forming a complex that links synaptic vesicles to presynaptic membranes. This interaction influences the dynamics of the membrane and ensures proper vesicle cycling during neurotransmission. Rabphilin 3A also interacts with calcium ions which regulate its affinity for other proteins involved in the synaptic machinery.

Pathways

Rabphilin 3A participates in the regulation of the neurotransmitter release pathway and synaptic vesicle cycle. It interacts with proteins like Rab3A to facilitate vesicle docking and membrane fusion important for synaptic vesicle exocytosis. The cAMP-dependent signaling pathway also involves Rabphilin 3A guiding the processes associated with synapse communication and plasticity.

Associated diseases and disorders

Rabphilin 3A appears to play a role in neurological disorders like epilepsy and neurodegenerative diseases. Its dysfunction is connected to altered synaptic transmission a factor in epilepsy pathophysiology. Rab3A a protein closely associated with Rabphilin 3A also impacts synaptic activity and their interplay may contribute to understanding diseases affecting synaptic function. Changes in Rabphilin 3A expression or function can lead to imbalances in neurotransmitter release highlighting its potential link to neurodegenerative conditions like Alzheimer's disease.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Sanger Sequencing - Human RPH3A knockout SK-N-FI cell line (ab288709), expandable thumbnail

    Sanger Sequencing - Human RPH3A knockout SK-N-FI cell line (ab288709)

    Homozygote. 43 bp deletion

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com